Area of research
Epidemiology · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Medicine, Type 2 diabetes, Placebo, Tolerability, Glycated hemoglobin, and Exenatide.
A multi-physically cross-linked roxadustat-loaded hydrogel for promoting diabetic wound healing via antibacterial, antioxidant and angiogenesis acceleration functions
Age‐dependent loss of hepatic <scp>SIRT1</scp> enhances NLRP3 inflammasome signaling and impairs capacity for liver fibrosis resolution
Targeting hepatic serine-arginine protein kinase 2 ameliorates alcohol-associated liver disease by alternative splicing control of lipogenesis
Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial
Comparative effectiveness of metformin monotherapy in extended release and immediate release formulations for the treatment of type 2 diabetes in treatment‐naïve Chinese patients: Analysis of results from the CONSENT trial
Comparison of the effects on glycaemic control and β‐cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel‐group trial (the <scp>CONFIDENCE</scp> study)